Fixed-dose combination of nucleoside reverse transcriptase inhibitor, nucleoside analogue, and non-nucleoside inhibitor in tablets for first-line HIV therapy in resource-limited settings. Provided by international aid organizations and generic suppliers to NGOs and public clinics worldwide.